Prevalence of multiple chronic conditions in New York State, 2011-2016.

07:00 EST 7th February 2019 | BioPortfolio

Summary of "Prevalence of multiple chronic conditions in New York State, 2011-2016."

To design effective policy and interventions, public health officials must have an accurate and granular picture of the state of multiple chronic conditions (MCC) in their region. The objective of this research is to describe the prevalence and distribution of MCC in New York State.


Journal Details

This article was published in the following journal.

Name: PloS one
ISSN: 1932-6203
Pages: e0211965


DeepDyve research library

PubMed Articles [30534 Associated PubMed Articles listed on BioPortfolio]

Healthcare Providers' Advice on Lifestyle Modification in the US Population: Results from the National Health and Nutrition Examination Survey 2011-2016.

Healthcare providers are encouraged to prescribe lifestyle modifications for preventing and managing obesity and associated chronic conditions. However, the pattern of lifestyle advice provision is un...

Diagnosed Diabetes Prevalence and Risk Factor Rankings, by State, 2014-2016: A Ring Map Visualization.

Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016.

In the U.S. household population aged 18 years (2011-2016), prevalence of hepatitis B surface antigen (HBsAg) was 0.36% overall, and was highest in non-Hispanic Asians (3.4%). Among adult HBsAg-carrie...

Urgent Care Center and Emergency Department Utilization for Non-Emergent Health Conditions: Analysis of Managed Care Beneficiaries.

The objective was to identify predictors of utilization for urgent care centers (UCCs), emergency departments (EDs), or for both services for non-emergent health conditions among beneficiaries from a ...

Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults - United States, 2016.

Chronic pain, one of the most common reasons adults seek medical care (1), has been linked to restrictions in mobility and daily activities (2,3), dependence on opioids (4), anxiety and depression (2)...

Clinical Trials [16559 Associated Clinical Trials listed on BioPortfolio]

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

This is a proposal for a retrospective observational study of the safety of metformin use in patients with chronic kidney disease, compared to other commonly used diabetes drugs. It will b...

Centralized Reminder Recall - Flu RCT2

This study is related to a previous study, ID: NCT02924467. There are some modifications in relation to the intervention arms as well as the use of a different cohort, t...

Fingolimod Real World Experience: the French Grand-Est Cohort

Objectives: This study describes efficacy and safety of Fingolimod in patients treated for at least 6 months in the east of France from January 2011 to December 2014. Background: The Gran...

The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease

The investigators will evaluate the prevalence of lung cancer associated with interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) utilizing the Korean Health Insurance ...

The Use of Resting State, fMRI and DTI in the Identification of Chronic Pain Conditions

Resting state fMRI scans of chronic pain sufferers will be compared to those of healthy normals and may be sufficiently different to allow a high level of classification accuracy of whethe...

Medical and Biotech [MESH] Definitions

City located at the mouth of the Hudson River, in New York State.

State bounded on the north by New York and Pennsylvania, on the east by New York and the Atlantic Ocean, on the south by Delaware Bay, and on the west by Pennsylvania.

Two or more concurrent chronic physical, mental, or behavioral health problems in an individual.

A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)

State bounded on the north by Canada, on the east by New Hampshire, on the south by Massachusetts, and on the west by New York.

Quick Search


DeepDyve research library

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Searches Linking to this Article